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Abstract
Background: Given that advances in research continuously raise new ethical issues, a multidisciplinary working
group of investigators involved in biomedical research has gathered to discuss and compare ethical viewpoints in
their daily practice.
Methods: The working group has drafted a Charter for Ethics in Biomedical Research that encompasses all the
steps in the research process, i.e. from the initial idea to analysis and publication of the results.
Results: Based on key principles for ethically responsible research, the Charter may serve as a tool for performing
research, discussing research issues and training researchers.
Conclusions: The Charter should stimulate researchers to think about their responsibility for research in a progressive,
caring society.
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Introduction
Over the past few decades, outstanding progress in the
field of biotechnology has increased awareness of ethical
issues. Researchers, national bodies and international or-
ganizations have therefore been prompted to develop
guidelines on research ethics and integrity [1].
A well-known chapter in the history of research with
human subjects opened after World War II, with the es-
tablishment of the Nuremberg Code [2]. This was
followed by the Declaration of Helsinki, which consti-
tutes the basis for all subsequent national and inter-
national ethical guidelines [3]. However, the ethical
concepts in these important international guidelines do
not cover aspects of daily research practice. In the field
of biotechnology, a range of questions concern aspects
of a researcher’s day-to-day work: training, practice, soci-
etal and professional roles, objectivity, credibility, evalu-
ation and constraints. In 1983, France was the first
country to create a National Consultative Committee on
Ethics in the Health and Life Sciences (Comité Consultatif
National d'Ethique pour les sciences de la vie et de la
santé, CCNE) to “provide advice on ethical issues and so-
cial issues raised by the progress of knowledge in the fields
of biology, medicine and health”. Soon after the founda-
tion of the CCNE, France introduced legislation on the
creation of ethics forums and “Think Tanks” in French
hospitals. Hence, Lille University Hospital and the Lille
Faculty of Medicine launched the Espace Ethique Hospita-
lier et Universitaire de Lille (EEHU; http://www.eehu-lil
le.fr/) in 2010. Since 2012, the “Ethics and Research”
working group has met within the framework of the
EEHU (under the impetus of Dr Eduardo Dei Cas [4–6])
to consider the role of life and health science researchers
in a university hospital in the 21st century (from funda-
mental research to clinical applications). After a number
of multidisciplinary debates on issues generated by the re-
search, progress in research and the representations of re-
search that ensue, the group came to feel that the fruit of
its discussions could be usefully summed up as a guide to
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ethical issues for researchers. The present Charter for Bio-
medical Research Ethics in a Progressive, Caring Society is
intended to be simple, open to challenge and revision, and
accessible to all researchers and stakeholders involved in
health and life science research. The Charter provides a
number of practical tools for researchers:
– A tool for improving research and ethical practices:
Enhancing the quality and legitimacy of research,
emphasizing the researcher’s individual responsibility
and promoting personal consideration and collective
debate on research ethics.
– A tool for debate and dialogue within research
groups: Facilitating interactions within the research
group, between research groups, and between
research groups and institutions.
– A training tool for students and young researchers:
Facilitating learning and counselling, encouraging
the proper supervision of young researchers,
fostering their awareness of ethics and introducing
them to research ethics.
Materials and methods
Constitution of an “Ethics and Research” working group
In 2011, individual and institutional stakeholders in the
life and health sciences based in and around the city of
Lille (northern France) were invited to form a working
group. Notably, people with expertise in medicine, phar-
macy, dentistry, nursing, sports science, biology, chemistry,
physics, literature, philosophy and languages were invited
to participate. Ultimately, a group of 14 people from a wide
range of areas of biomedical research met to discuss re-
search ethics (Table 1). The group meets every two months
to discuss issues and share its members’ experiences. It
combines critical thinking and ethical analysis within a
framework of discourse ethics [7]. The group’s mission
goes beyond normative ethics, although it does question
the sources, grounds, and legitimacy of ethical matters.
Methods
The “Ethics and Research” working group searched elec-
tronic databases and the Internet to identify articles, re-
views, editorials, books or any related content in
academic journals and/or on websites that refer to re-
search ethics, a charter for ethics in biomedical research
or research integrity. The analysis included international
charters (such as the Singapore Statement on Research
Integrity), national charters (such as those established in
Belgium and Sri Lanka) and ethical charters drafted by
learned societies [2, 8–10].
Results
The charter for biomedical research ethics
The Charter for Biomedical Research Ethics is based on
debate, open-mindedness and dialogue [4–6, 8–12]. Ra-
ther than imposing additional constraints on researchers,
the Charter’s objective is to put forward common points
Table 1 The members of the multidisciplinary “Ethics and Research” working group
First name and family name Qualifications/position/field of research Affiliation
Alessandra Blaizot DDS, MSc/Ethics CHRUa of Lille, University Hospital, University
of Lille
Danie Boudiguet Director of Nursing, Nurse anaesthetist (I.A.D.Eb
school) RNA/Teaching and training
CHRU of Lille, University Hospital
Valérie Bougault PhD/Physiology & Sport sciences University of Lille
Eduardo Dei Cas MD, PhD/Mycology & Parasitology CHRU of Lille, University Hospital, University
of Lille
Laurence Delhaes MD, PhD/Mycology & Parasitology CHRU of Lille, University Hospital, University
of Lille
Benoît Foligné PhD/Microbiology & Immunology Institut Pasteur de Lille, University of Lille
Anne Goffard MD, PhD/Virology CHRU of Lille, University of Lille
Hélène Lefranc BSc, Hospital Engineer at DRCIc,, Clinical Research
Project Manager/Research Management
CHRU of Lille University Hospital
Bénédicte Oxombre-Vanteghem PhD/Neuro-immunology University of Lille
Thomas Trentesaux DDS, PhD/Ethics CHRU of Lille, University Hospital, University of Lille
Bernard Vandenbunder Vandenbunder PhD/Physics - Cell Biology - Biophotonics Centre National de la Recherche Scientifique
Sylvie Vandoolaeghe MSc, Assistant Coordinator of the Lille
EEHU$$/Philosophy
CHRU of Lille, University Hospital
Isabelle Wolowczuk PhD/Immunology and metabolism Centre National de la Recherche Scientifique
aCentre Hospitalier Régional et Universitaire. bInfirmier Anesthésiste Diplômé d’Etat. cDélégation à la Recherche Clinique et à l’Innovation. $$RNA Registered Nurse
Anaesthetist, Centre National de la Recherche Scientifique. EEHU Espace Ethique Hospitalier et Universitaire
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of reference and principles for action for those working
in the fields of life and health science.
The Charter is based on the following principles:
Integrity, honesty, impartiality, transparency and
critical thinking.
Competence, accuracy, rigorousness, precision and
verifiability.
Caution, carefulness, respect, confidentiality and
reliability.
Independence of mind, creativity, open-mindedness
and altruism.
The Charter describes how these principles can be
translated into actions during the different steps in the
research process, from the initial working hypothesis to
publication and dissemination of the results and consid-
eration of opportunities for further research. The Char-
ter addresses the following five aspects of research:
Defining the context and objectives of research
As an essential prerequisite to a research project, the re-
searcher must determine the “state of the art”. This en-
ables her/him to (i) present and acknowledge the field’s
results and current limitations (integrity and honesty),
(ii) cite the corresponding authors, and (iii) think of
ways of advancing the state of the art (critical thinking
and open-mindedness).
The researcher should precisely define her/his working
hypothesis by delimiting the field of investigation (rigor-
ousness). She/he should take account of what is known
from previous research, while seeking to add value. Ac-
cordingly, she/he will justify her/his efforts to make fur-
ther progress (creativity and altruism).
Selecting materials and setting up methods
Methodology (integrity, rigorousness and verifiability)
The researcher should select the methodology that is
best suited to answering the research question. Methods
should not be chosen or adapted in order to obtain pre-
defined results. The researcher must check that the
chosen materials and methods are appropriate and can
be used optimally under the research project’s various
constraints. She/he must seek to reduce experimental
bias as much as possible, while considering the limita-
tions of her/his approach.
From the beginning of the work onwards, all raw data
should be stored so as to ensure rigorousness and trans-
parency in accordance with current legislation. This re-
quirement covers the research hypothesis, communication
with various organizations or journals, bibliographic refer-
ences, the methods used, the data collected, and the struc-
turing, analysis, publication and communication of results.
Compliance with these criteria helps to structure the
research and enables research processes to be verified and
replicated.
Commitments, interests and working relationships
The researcher must not overrate her/his work or mis-
lead funding bodies, research institutions, colleagues, the
media or the general public (integrity, honesty, and
accuracy).
The researcher must state the identity of her/his spon-
sors and funding sources and must describe the nature
of relationship(s) she/he has with them (e.g. acting as a
consultant or an expert advisor). She/he must declare
any personal, professional or financial interests in order
to maintain the necessary level of trust in her/his own
research and (as an extended responsibility) in research
in general. In the event of a potential conflict of interest,
the researcher can only agree to participate if her/his
impartiality is beyond doubt.
When a researcher is asked to engage in a research ac-
tivity, she/he must always honestly estimate her/his ability
to successfully complete that activity. She/he should com-
mit to maintaining and upgrading her/his skill level and
knowledge and to achieving proficiency in the techniques
required to advance her/his research (competence).
The researcher must carry out her/his research in ac-
cordance with the current legislation and deontological
and institutional guidelines, rules and regulations (legality).
She/he must respect the colleagues and students
which whom she/he works by treating them fairly and
without subjecting them to discrimination or any kind
of abuse (respect, courtesy and loyalty in working rela-
tionships within the group, between groups, towards her/
his colleagues and hierarchy). She/he should seek to
manage tensions within a group as best she/he can and
must acknowledge the constraints related to employ-
ment contracts.
Participants (caution, carefulness, respect, confidentiality
and reliability)
The researcher and her/his institution are ethically
obliged to take account of the risk-benefit ratio associ-
ated with research work. In clinical research, the “sub-
jects” are human beings and so their dignity, freedom
and privacy must be protected. The researcher must
minimize the risk of harm to others, and should act with
caution and foresight. She/he should take specific pre-
cautions to protect vulnerable persons. When the re-
search is performed in a country other than her/his own,
she/he should respect the local culture and environment.
She/he should admit to and correct (to the greatest ex-
tent possible) any mistakes, omissions or damage caused.
Moreover, the researcher must be cautious and take pre-
cautions if her/his experiments are likely to have an en-
vironmental impact.
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For biomedical research involving human subjects, the
sponsor must obtain approval from the relevant inde-
pendent ethics committee/investigational review board.
If animals are used, the researcher must treat them care-
fully and respectfully. She/he must limit the animals’ suf-
fering, in line with the “3Rs” (Reduction, Replacement,
and Refinement). She/he must not implement an unneces-
sary or poorly designed animal experiment or any animal
experiment that has not been approved by the relevant in-
stitutional animal care and use committee.
Analysing results
When analysing research results, the researcher must
not disclose confidential personal data (respect, careful-
ness and confidentiality). The researcher should not be
let her/his preconceived ideas influence the analysis or
interpretation of her/his results. She/he should differen-
tiate between her/his own opinions and the scientific ex-
periment (impartiality). She/he must also distinguish
between hypotheses and speculations on one hand and
the results and conclusions of her/his research on the
other (accuracy). The researcher should avoid bias when
analysing and interpreting her/his own data. According,
peer reviews or reviews of a colleague’s work should be
objective (integrity and objectivity).
The researcher must seek to avoid negligence (rigorous-
ness). She/he should maintain a critical view of her/his
own work and that of her/his peers - particularly during
collaborative work (critical thinking). In interdisciplinary
projects, she/he should place the requisite trust in col-
leagues and pay attention to the different views that they
may bring to her/his area of expertise (open-mindedness).
A researcher’s analysis of the results and her/his subse-
quent establishment of the conclusions must be driven
by a requirement for truth and knowledge. The research
must not be transferred too quickly to the media or
business stakeholders outside the scientific community.
These results must not be falsified by constraints, obliga-
tions or pressure. In contrast, results should not be set
aside for too long in an effort to “protect” them.
When the researcher evaluates the research of her/his
peers, she/he should carry out the mission thoroughly,
fairly and without disclosing confidential information.
She/he shall review papers and grant applications in a
timely manner and from a neutral viewpoint, and must
be guided solely by scientific considerations. Reviewing
is an important part of her/his overall responsibility to
the discipline of research. When supervising students,
she/he shall offer appropriate advice and promote com-
petence and responsibility (responsible tutoring).
Communicating and publishing research results
The researcher must comply with patent rights, copy-
right and other intellectual property rights. She/he
acknowledges other people’s work and contributions.
She/he must not present other people’s work as her/his
own. She/he must respect her/his colleagues’ ideas and
never plagiarize them [8] (honesty and accuracy).
The researcher accepts responsibility for her/his con-
tributions as a group member, co-author or author.
When publishing, the author should honestly distinguish
between (i) co-authors who meet the criteria for author-
ship and (ii) colleagues who should solely be acknowl-
edged (i.e. minor contributors).
The principal investigator should appropriately man-
age her/his group members’ respective contributions by
precisely defining their respective roles (rigorousness).
The researcher should communicate her/his results in
a timely and open manner, in order to establish owner-
ship of intellectual property and establish priority. Raw
data must be stored, so that they can be validated and/or
replicated (transparency, rigorousness, precision and veri-
fiability). The researcher takes account of all her/his re-
sults - including unwanted or unexpected ones – and
should not filter them arbitrarily (accuracy). She/he
should not disclose confidential information on patients,
participants or other people involved in research before,
during or after publication of the results (confidential-
ity). However, on request, the results should be made
available to the participants.
Defining follow-up actions and perspectives for further
research
By performing high-quality research with integrity, the
researcher creates and maintains confidence in her/his
work. In this respect, she/he must be alert to any lack of
integrity within her/his research group (responsibility).
In order to enable and promote responsible behaviour
by the researcher, her/his research environment should:
– promote competence via access to continuing
education and training.
– set clear, realistic working rules that are compatible
with the research project’s time-frame and
constraints.
– implement appropriate actions to correct or retract
publications, if required.
– define fair criteria for career advancement and thus
enable both individual and collective development.
Discussion
Scientific research is rooted in the quest for truths and
knowledge that serve humanity; it fits into a vision of a
progressive, caring society. Researchers must have free-
dom of speech and intellectual independence with
regard to their science, from hypotheses through to im-
plementation and conclusions. In this respect, funding
agreements are drawn up to precisely define the rights
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and obligations of each party (including those of the re-
search institution) and to manage intellectual property,
communication and exploitation of the results. However,
the research process must always leave some room for
serendipity.
Given that (i) today’s societies have many points of refer-
ence, (ii) scientific and biomedical practices are constantly
evolving and (iii) the use of scientific and biomedical prac-
tices may create dilemmas and raise obstacles, we need to
find a way of thinking about research ethics that enables
us to question the legitimacy of the means employed and
the research’s possible consequences. This approach is ne-
cessarily placed in a specific context - here and now, with
circumstances, constraints, a past and a future. The
present Charter for Biomedical Research Ethics is not a
tool for accrediting a given research project as being "eth-
ical" or not; in fact, it incites each researcher to think
about the objectives she/he defines, the means she/he uses
to achieve them, and the risks and limitations related to
her/his research. Accordingly, the researcher takes respon-
sibility not only for her/his own research but also for re-
search in general.
Research in the life and health sciences generates rep-
resentations of the living world [12] via (a) frameworks
for conceptualizing research hypotheses, (b) biomedical
practices (in which a patient is considered as an object,
e.g. in biotechnology), (c) policies on precaution and
prevention, (d) education and training [13, 14], (e) a ra-
tionale for political decisions on biological research, (f )
perceptions and images of the living world conveyed by
the media and in the cultural and artistic domains.
Biomedical research deals with emergence of the com-
plexity of the living world in its universality and singularity,
which requires open-mindedness, critical thinking, multiple
analytical strategies, creativity and unceasing conscientious-
ness. In view of the complexity and social impacts of re-
search and its mutually stimulating disciplines (biomedical
science, the human and social sciences, etc.), it is essential
to question research’s resources, limitations and meaning.
What are we aiming to achieve? What can be expected?
What should be avoided? How can science and society
move forward? As its title suggests, the present Charter for
Ethics in Biomedical Research is primarily aimed at re-
searchers in the fields of life and health sciences worldwide.
However, it could be useful for other stakeholders in the
paramedical professions and/or other fields of science. In-
deed, when disciplines meet or are confronted with one an-
other, a new vision of the living world – perhaps better
adjusted to the complexity of life – may emerge. Along
these lines, today’s research programmes are growing at the
interfaces between nanoscience, computer science and
biology. Some researchers recommend a global, integrated
approach for strengthening the links between human
health, animal health and environmental care (the “One
Health” concept, for example [15]). Another example is the
interdisciplinary workgroups (including representatives of
the human and social sciences) organized by the North
American “Global Health” consortium [16]. The European
Union’s research directives for the “Horizon 2020” program
[17] also encourage various types of multidisciplinary and/
or international cooperation; these correspond to an in-
novative, globally coherent vision of issues that require
international guidelines for research integrity [18].
In conclusion, we believe that present Charter for Eth-
ics in Biomedical Research (based on common princi-
ples) will evolve as a function of the context and
scientific progress. Ethical issues must be continually
questioned because they reflect the infinite complexity
of the living world. We consider that the living world is
focused on organisms and their future – organisms that
interact with each other and with their environment,
compatible with an ongoing world, simultaneously com-
plex, historical and open. Nevertheless, certain funda-
mental principles will always be applied, regardless of
contextual and conceptual changes.
Competing interest
The authors declare that they have no conflicts of interest.
Authors’ contributions
All authors (SV, AB, DB, VB, EDC, BF, AG, HL, BO, TT, BV, IW and LD) collected
and reviewed the literature, contributed to discussions on ethics and
reviewed the manuscript for critical content. SV, AG, BF, BV, IW and LD wrote
the manuscript. All authors read and approved the final manuscript.
Acknowledgments
The authors thank Catherine Brossaud (Senior Health Manager, IFCS, CHRU
Lille) for her unceasing interest in the working group and its discussions;
Nico Decock (Nurse Anaesthetist Trainer at the School of Nurse Anaesthetists,
Lille-2 University) for his attentive and critical reading of the manuscript; and
Dr David Fraser (Biotech Communication SARL, Damery, France) for editorial
assistance.
In memoriam
The parasitologist Dr Eduardo Dei-Cas (1945–2014) was one of the leading
experts on the opportunistic fungus Pneumocystis. In 2000, he initiated a
debate on ethics in biology, medicine and research at Lille Universities,
France. He was particularly interested in the debate concerning emergence
and reductionism. Dr Dei-Cas notably participated in seminars as a member
of the Centre for Medical Ethics (CME, Catholic Institute of Lille, Lille, France),
organized a symposium on ethical and epistemological questions at the
EMOP X (Paris, 2008), and shared his expertise during a course on “Dealing
with the ethics of the living world” (Philosophy Research Unit, University of
Lille 3 – Professor F. Worms) (2007–2012). In 2012, Dr Eduardo Dei-Cas
launched the present “Ethics and Research” working group in the Ethics
Department (Espace Ethique Hospitalier et Universitaire de Lille, EEHU) at Lille
University and University Hospital.
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